Blog

BlogAugust 25, 2023

Should Psychedelic Therapists Get a Taste of Their Own Medicine?

BlogAugust 22, 2023

Atai Life Sciences: State of the Company and Projections for the Future

BlogAugust 18, 2023

How Crowdfunding is Fueling Growth in the Psychedelic Industry

BlogAugust 17, 2023

Mind Cure Health Inc. (To Be Renamed LNG Energy Group Corp.) Announces Completion of Business Combination Transaction

BlogAugust 16, 2023

Melissa Lavasani Advocates for Psychedelic Medicines – Podcast Episode #34

BlogAugust 16, 2023

Cybin Finacial Analysis: Future Prospects are Uncertain

BlogAugust 15, 2023

COMPASS Pathways Financial Analysis: Road to Profitability

BlogAugust 10, 2023

Psychedelic Legalization is Contagious: Here is Where It is Happening

BlogAugust 7, 2023

Braxia Scientific Financial Report Analysis

BlogAugust 4, 2023

Psychedelics and SSRIs: What the Science Says

BlogAugust 2, 2023

Fraser Johnston Inspires Healthy and Cooperative Communities – Podcast Episode #33

BlogAugust 2, 2023

Cybin Brings in Capital with Public Offering

BlogAugust 1, 2023

Psychedelic Access is Coming to California

BlogJuly 28, 2023

Numinus Earnings Report Analysis— Q3 2023: Bullish Vs Bearish?

BlogJuly 27, 2023

How I Overcame My Nicotine Addiction with Magic Mushrooms

BlogJuly 27, 2023

Treating Anorexia with Psychedelics

BlogJuly 25, 2023

Unleashing the Potential of Psychedelic Science with Kernel Flow

BlogJuly 24, 2023

Samuel Becht Personalizes Preparation and Integration – Podcast Episode #32

BlogJuly 13, 2023

Legal Battles and Investor Concerns: FSD Pharma’s Rocky Road

BlogJuly 6, 2023

Carina Cunha Helps You Find the Right Psychedelic Experiences – Podcast Episode #31

BlogJune 28, 2023

Insurance Coverage for Psychedelic Treatment: Breaking Down the Costs and Access

BlogJune 22, 2023

Bjørn Hansen & Nathaniel Morris are Enhancing Sexual Wellness with Technology – Podcast Episode #30

BlogJune 22, 2023

What’s Next?— Predictions for What Happens After MDMA is Approved

BlogJune 15, 2023

Breaking Political Boundaries: The Surprising Political Consensus on Psychedelics